GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Cyclically Adjusted Revenue per Share

Accelerate Diagnostics (STU:1A80) Cyclically Adjusted Revenue per Share : €1.08 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Accelerate Diagnostics's adjusted revenue per share for the three months ended in Mar. 2024 was €0.140. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.08 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Accelerate Diagnostics's average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 19.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Accelerate Diagnostics was 19.70% per year. The lowest was -32.60% per year. And the median was -3.70% per year.

As of today (2024-06-06), Accelerate Diagnostics's current stock price is €1.07. Accelerate Diagnostics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €1.08. Accelerate Diagnostics's Cyclically Adjusted PS Ratio of today is 0.99.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Accelerate Diagnostics was 512.71. The lowest was 0.70. And the median was 221.53.


Accelerate Diagnostics Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Accelerate Diagnostics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Cyclically Adjusted Revenue per Share Chart

Accelerate Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.52 0.67 0.83 1.06

Accelerate Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.86 0.96 1.06 1.08

Competitive Comparison of Accelerate Diagnostics's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Accelerate Diagnostics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerate Diagnostics's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Cyclically Adjusted PS Ratio falls into.



Accelerate Diagnostics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Accelerate Diagnostics's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.14/131.7762*131.7762
=0.140

Current CPI (Mar. 2024) = 131.7762.

Accelerate Diagnostics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.002 100.560 0.003
201409 0.003 100.428 0.004
201412 0.014 99.070 0.019
201503 0.003 99.621 0.004
201506 0.004 100.684 0.005
201509 0.018 100.392 0.024
201512 0.004 99.792 0.005
201603 0.029 100.470 0.038
201606 0.004 101.688 0.005
201609 0.004 101.861 0.005
201612 0.007 101.863 0.009
201703 0.096 102.862 0.123
201706 0.116 103.349 0.148
201709 0.126 104.136 0.159
201712 0.323 104.011 0.409
201803 0.117 105.290 0.146
201806 0.268 106.317 0.332
201809 0.214 106.507 0.265
201812 0.296 105.998 0.368
201903 0.285 107.251 0.350
201906 0.293 108.070 0.357
201909 0.378 108.329 0.460
201912 0.571 108.420 0.694
202003 0.387 108.902 0.468
202006 0.340 108.767 0.412
202009 0.539 109.815 0.647
202012 0.447 109.897 0.536
202103 0.361 111.754 0.426
202106 0.380 114.631 0.437
202109 0.434 115.734 0.494
202112 0.447 117.630 0.501
202203 0.396 121.301 0.430
202206 0.479 125.017 0.505
202209 0.344 125.227 0.362
202212 0.288 125.222 0.303
202303 0.267 127.348 0.276
202306 0.245 128.729 0.251
202309 0.212 129.860 0.215
202312 0.190 129.419 0.193
202403 0.140 131.776 0.140

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Accelerate Diagnostics  (STU:1A80) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Accelerate Diagnostics's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.07/1.08
=0.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Accelerate Diagnostics was 512.71. The lowest was 0.70. And the median was 221.53.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Accelerate Diagnostics Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerate Diagnostics (STU:1A80) Business Description

Traded in Other Exchanges
Address
3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics (STU:1A80) Headlines

No Headlines